请输入您要查询的百科知识:

 

词条 Phenmetrazine
释义

  1. History

  2. Medical use

  3. Pharmacology

  4. Chemistry

  5. Recreational use

  6. See also

  7. References

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464200421
| IUPAC_name = 3-methyl-2-phenylmorpholine
| image = Phenmetrazine.svg
| width = 125
| tradename =
| legal_AU = S8
| legal_CA = Schedule IV
| legal_UK = Class B
| legal_US = Schedule II
| legal_DE = Anlage II
| routes_of_administration = Oral, Intravenous, Vaporized, Insufflated, Suppository
| elimination_half-life = 8 hours
| excretion = Renal
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 134-49-6
| ATC_prefix = none
| PubChem = 4762
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00830
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4598
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = XA501VL3VR
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = C07432
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201208
| C=11 | H=15 | N=1 | O=1
| molecular_weight = 177.2456
| smiles = CC1C(C2=CC=CC=C2)OCCN1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H15NO/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10/h2-6,9,11-12H,7-8H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OOBHFESNSZDWIU-UHFFFAOYSA-N
}}

Phenmetrazine (INN, USAN, BAN) (brand name Preludin, and many others) is a stimulant drug that was previously used as an appetite suppressant, but has since been withdrawn from the market. It was initially replaced by its analogue phendimetrazine which functions as a prodrug to phenmetrazine, but now it is rarely prescribed, due to concerns of abuse and addiction. Chemically, phenmetrazine is a substituted amphetamine with a morpholine ring.

History

Phenmetrazine was first patented in Germany in 1952 by Boehringer-Ingelheim,[1][2] with some pharmacological data published in 1954.[3] It was the result of a search by Thomä and Wick for an anorectic drug without the side-effects of amphetamine.[4] Phenmetrazine was introduced into clinical use in 1954 in Europe.[5]

Medical use

In clinical use, phenmetrazine produces less nervousness, hyperexcitability, euphoria and insomnia than drugs of the amphetamine family.[6] It tends not to increase heart rate as much as other stimulants. Due to the relative lack of side effects, one study found it well tolerated in children.[4] In a study of the effectiveness on weight loss between phenmetrazine and dextroamphetamine, phenmetrazine was found to be slightly more effective.[7]

Pharmacology

Phenmetrazine acts as a releasing agent of norepinephrine and dopamine with EC50 values of 50.4 ± 5.4 nM and 131 ± 11 nM, respectively.[8] It has negligible efficacy as a releaser of serotonin, with an EC50 value of only 7,765 ± 610 nM.[8]

After an oral dose, about 70% of the drug is excreted from the body within 24 hours. About 19% of that is excreted as the unmetabolised drug and the rest as various metabolites.[9]

In trials performed on rats, it has been found that after subcutaneous administration of phenmetrazine, both optical isomers are equally effective in reducing food intake, but in oral administration the levo isomer is more effective. In terms of central stimulation however, the dextro isomer is about 4 times as effective in both methods of administration.[10]

Chemistry

{{Expand section|1=details of the synthesis from US patent [https://www.google.com/patents/US3018222 US3018222]|date=January 2015}}

Its structure incorporates the backbone of amphetamine, the prototypical CNS stimulant which, like phenmetrazine, is a releasing agent of dopamine and norepinephrine. The molecule also loosely resembles ethcathinone, the active metabolite of popular anorectic amfepramone (diethylpropion). Unlike phenmetrazine, ethcathinone (and therefore amfepramone as well) are mostly selective as noradrenaline releasing agents.

Recreational use

Phenmetrazine has been used recreationally in many countries such as Sweden. When stimulant use first became prevalent in Sweden in the 1950s, phenmetrazine was preferred to amphetamine and methamphetamine by users.[11] In the autobiographical novel Rush by Kim Wozencraft, intravenous phenmetrazine is described as the most euphoric and pro-sexual of the stimulants the author used.

Phenmetrazine was classified as a narcotic in Sweden in 1959, and was taken completely off the market in 1965. At first the illegal demand was satisfied by smuggling from Germany, and later Spain and Italy. At first, Preludin tablets were smuggled, but soon the smugglers started bringing in raw phenmetrazine powder. Eventually amphetamine became the dominant stimulant of abuse because of its greater availability.

Phenmetrazine was taken by the Beatles early in their career. Paul McCartney was one known user. McCartney's introduction to drugs started in Hamburg, Germany. The Beatles had to play for hours, and they were often given the drug (referred to as Prellies) by the maid who cleaned their housing arrangements, German customers, or by Astrid Kirchherr (whose mother bought them). McCartney would usually take one, but John Lennon would often take four or five.[12] Hunter Davies asserted, in his 1968 biography of the band,[13] that their use of such stimulants then was in response to their need to stay awake and keep working, rather than a simple desire for kicks.

Jack Ruby said he was on phenmetrazine at the time he killed Lee Harvey Oswald.[14]

Preludin was also used recreationally in the US throughout the 1960s and early 1970s. It could be crushed up in water, heated and injected. The street name for the drug in Washington, DC was "Bam".[15] Phenmetrazine continues to be used and abused around the world, in countries including South Korea.[16]

See also

  • Substituted phenylmorpholine
  • 3-Benzhydrylmorpholine
  • Fenbutrazate
  • Edivoxetine
  • Morazone
  • Reboxetine
  • The Beatles drug use in Hamburg
  • 3-Fluorophenmetrazine

References

1. ^{{cite news| first1= Albert| last1= Boehringer| first2= Ernst | last2= Boehringer| title= Improvements in or relating to the preparation of substituted morpholines| number= GB773780}}
2. ^{{cite patent| url= http://www.google.com/patents/US2835669 |country= US| status= Patent |title= Process for the Production of Substituted Morpholines | number= 2835669 | via= google.com| gdate= May 20, 1958| fdate= June 29, 1953| invent1= Otto Thoma| assign1= C. H. Boehringer Sohn}}
3. ^{{cite journal|last1= Thomä| first1= O |last2= Wick| first2= H |lastauthoramp=yes | title=Über einige Tetrahydro-1,4-oxazine mit sympathicomimetischen Eigenschaften| journal=Arch. Exp. Pathol. Pharmakol.| volume=222| year=1954| pages=540}}
4. ^{{cite journal| last= Martel| first= Antonio| title=Preludin (Phenmetrazine) in the Treatment of Obesity| journal=Can. Med. Assoc. J.| volume=76| year=1957| pages=117–20| pmid=13383418| issue=2| pmc=1823494}}
5. ^{{cite book| last= Kalant| first= Oriana Josseau| title=The Amphetamines: Toxicity and Addiction| year=1966| isbn=0-398-02511-8}}
6. ^{{cite journal| title=Phenmetrazine Hydrochloride| journal=J. Am. Med. Assoc.| volume=163| issue=5| pages=357| year=1957}}
7. ^{{cite journal| title=Phenmetrazine and Dexamphetamine in the Management of Obesity| author=Hampson, J| journal=The Lancet| volume=275| issue=7137| pages=1265–7| year=1960| doi=10.1016/S0140-6736(60)92250-9| pmid=14399386| last2=Loraine| first2=J.A.| last3=Strong| first3=J.A.}}
8. ^{{cite journal |vauthors=Rothman RB, Baumann MH | title = Therapeutic potential of monoamine transporter substrates | journal = Current Topics in Medicinal Chemistry | volume = 6 | issue = 17 | pages = 1845–59 | year = 2006 | pmid = 17017961 | doi = 10.2174/156802606778249766| url = http://www.bentham-direct.org/pages/content.php?CTMC/2006/00000006/00000017/0004R.SGM}}
9. ^{{cite book| title=Clarke's Analysis of Drugs and Poisons| author=Anthony C Moffat, M David Osselton and Brian Widdop| isbn=0-85369-473-7}}
10. ^{{cite journal| title=Studies of the Mechanism of the Anti-Appetite Action of Phenmetrazine| author=Engelhardt, A| journal=Biochem. Pharmacol.| volume=8| issue=1| pages=100| year=1961| doi=10.1016/0006-2952(61)90520-2}}
11. ^{{cite web| url=http://www.druglibrary.org/schaffer/LIBRARY/studies/cu/CU39.html| title=The Swedish Experience| author=Brecher, Edward M| accessdate=2009-10-31}}
12. ^{{cite book| last= Miles| first= Barry| title=Paul McCartney: Many Years from Now| year=1998 |pages=66–67| isbn=0-8050-5248-8}}
13. ^{{cite book| authorlink= Hunter Davies| last= Davies| first= Hunter| title=The Beatles: The Authorized Biography| year=1968 |page=78| isbn=0-07-015457-0}}
14. ^{{cite book| first= Jack| last= Ruby |title= Testimony of Jack Ruby| volume= 5| place= Washington| publisher= US Government Printing Office| year= 1964| pages= 198–99}}
15. ^{{cite book | first= Leon| last= Dash | title = Rosa Lee | publisher = HarperCollins | year = 1996 | page = 109}}
16. ^{{cite journal |vauthors=Choi H, Baeck S, Jang M, Lee S, Choi H, Chung H | title = Simultaneous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases | journal = Forensic Science International | volume = 215 | issue = 1–3 | date = 10 February 2012 | pages = 81–87 | pmid= 21377815 | doi=10.1016/j.forsciint.2011.02.011}}
{{Stimulants}}{{Anorectics}}{{Monoamine releasing agents}}{{Phenethylamines}}

7 : Stimulants|Anorectics|Withdrawn drugs|Morpholines|Euphoriants|Norepinephrine-dopamine releasing agents|Substituted amphetamines

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/27 12:13:39